G&E Herbal Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	59.8	78.41	152.59	139.68	114.75	12.28
Short-Term Investments	361.9	351.9	256.29	173.24	91.2	96.6
Cash & Short-Term Investments	421.7	430.31	408.87	312.92	205.95	108.88
Cash Growth	-8.26%	5.24%	30.66%	51.94%	89.15%	-9.31%
Accounts Receivable	22.25	17.06	17.8	14.78	0.75	5.09
Other Receivables	0.26	0.24	0.16	0.15	0.02	0.03
Receivables	22.5	17.31	17.96	14.93	0.77	5.12
Inventory	27.04	25.3	21.71	22.9	24.64	19.83
Prepaid Expenses	2.6	1.78	2.38	1.41	1.32	2.07
Total Current Assets	473.85	474.69	450.92	352.17	232.69	135.9
Property, Plant & Equipment	365.5	366.04	372.31	375.12	375.15	382.85
Other Intangible Assets	132.58	132.73	133.33	133.89	134.68	135.51
Long-Term Deferred Tax Assets	9	0.35	0.26	19.65	37.95	37.59
Other Long-Term Assets	1.33	1.42	2.37	2.27	2.31	0.28
Total Assets	982.26	975.22	959.17	883.1	782.78	692.13
Accounts Payable	5.48	7.53	8.34	4.03	8.97	2.73
Accrued Expenses	2.43	15.48	17.72	17.34	8.11	1.64
Current Portion of Leases	0.6	0.78	0.88	0.69	-	-
Current Income Taxes Payable	16.25	15.62	3.1	-	-	-
Current Unearned Revenue	-	0.13	85.23	95.24	71.85	0.45
Other Current Liabilities	14.49	7.52	9.51	1.28	2.82	3.85
Total Current Liabilities	39.25	47.05	124.77	118.57	91.74	8.68
Long-Term Leases	0.05	0.09	0.87	1.29	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	0.2	-
Total Liabilities	39.3	47.15	125.64	119.86	91.94	8.68
Common Stock	637.2	637.2	590	556.6	556.6	556.6
Additional Paid-In Capital	134.24	134.24	134.24	134.24	273.33	273.33
Retained Earnings	171.53	156.64	109.3	72.4	-139.09	-146.47
Shareholders' Equity	942.96	928.07	833.53	763.24	690.84	683.45
Total Liabilities & Equity	982.26	975.22	959.17	883.1	782.78	692.13
Total Debt	0.65	0.87	1.75	1.98	-	-
Net Cash (Debt)	421.06	429.44	407.13	310.94	205.95	108.88
Net Cash Growth	-8.10%	5.48%	30.93%	50.98%	89.15%	-9.31%
Net Cash Per Share	6.61	6.72	6.38	4.88	3.23	1.71
Filing Date Shares Outstanding	63.72	63.72	63.72	63.72	63.72	63.72
Total Common Shares Outstanding	63.72	63.72	63.72	63.72	63.72	63.72
Working Capital	434.6	427.64	326.14	233.6	140.95	127.22
Book Value Per Share	14.80	14.56	13.08	11.98	10.84	10.73
Tangible Book Value	810.38	795.34	700.21	629.34	556.16	547.95
Tangible Book Value Per Share	12.72	12.48	10.99	9.88	8.73	8.60
Land	-	148.59	148.59	148.59	148.59	148.59
Buildings	-	233.86	233.58	233.58	233.08	233.39
Machinery	-	49.5	50.77	52.08	55.06	55.32
Construction In Progress	-	2.59	2.39	-	-	-
Leasehold Improvements	-	5.33	5.33	5.33	5.33	5.33